- ASGO 4th International Workshop on Gynecologic Oncology
-
Shibuya Y, Toyoshima , Yaegashi N
- KMID: 2413860
- J Gynecol Oncol.
- 2017 Jan;28(1):e24.
- doi: 10.3802/jgo.2017.28.e24
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
-
Ikeda M, Shida M, Shigeta S, Nagase S, Takahashi F, Yamagami W, Katabuchi H, Yaegashi N, Aoki D, Mikami M
- KMID: 2526401
- J Gynecol Oncol.
- 2021 May;32(3):e44.
- doi: 10.3802/jgo.2021.32.e44
Objective: The Japan Society of Gynecologic Oncology published the first guidelines for the treatment of cervical cancer in 2007. The aim of this research was to evaluate the influence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Lymphadenectomy issues in endometrial cancer
-
Konno Y, Asano H, Shikama A, Aoki D, Tanikawa M, Oki A, Horie K, Mitsuhashi A, Kikuchi A, Tokunaga H, Terao Y, Satoh T, Ushijima K, Ishikawa M, Yaegashi N, Watari H
- KMID: 2526370
- J Gynecol Oncol.
- 2021 Mar;32(2):e25.
- doi: 10.3802/jgo.2021.32.e25
Objectives: This review aims to introduce preoperative scoring systems to predict lymph node metastasis (LNM) and ongoing clinical trials to investigate the therapeutic role of lymphadenectomy for endometrial cancer. Methods: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer
-
Mikami M, Shida M, Shibata T, Katabuchi , Kigawa J, Aoki D, Yaegashi N
- KMID: 2404018
- J Gynecol Oncol.
- 2018 Mar;29(2):e23.
- doi: 10.3802/jgo.2018.29.e23
OBJECTIVE: The Japan Society of Gynecologic Oncology (JSGO) initiated a nation-wide training system for the education and certification for gynecologic oncologists in 2005. To assess the impact of the quality... -
- CITED
-
- Close
- SHARE
-
- Close
- Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan
-
Ikeda Y, Furusawa A, Kitagawa R, Tokinaga A, Ito F, Ukita M, Nomura H, Yamagami W, Tanabe H, Mikami M, Takeshima , Yaegashi N
- KMID: 2363323
- J Gynecol Oncol.
- 2016 May;27(3):e29.
- doi: 10.3802/jgo.2016.27.e29
OBJECTIVE: Although radiation therapy (RT) and concurrent chemoradiotherapy (CCRT) are the global standards for adjuvant therapy treatment in cervical cancer, many Japanese institutions choose chemotherapy (CT) because of the low... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
-
Kobayashi Y, Masuda K, Hiraswa A, Takehara K, Tsuda H, Watanabe Y, Oda K, Nagase S, Mandai M, Okamoto A, Yaegashi N, Mikami M, Enomoto T, Aoki D, Katabuchi H, Working Group on Clinical Practice for Cancer Genomic Medicine and HBOC, Japan Society of Gynecologic Oncology
- KMID: 2537910
- J Gynecol Oncol.
- 2022 Sep;33(5):e61.
- doi: 10.3802/jgo.2022.33.e61
Objective The practices pertaining to hereditary breast and ovarian cancer (HBOC) in Japan have been rapidly changing owing to the clinical development of poly(ADP-ribose) polymerase inhibitors, the increasing availability of companion... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study
-
Machida H, Matsuo K, Oba K, Aoki D, Enomoto T, Okamoto A, Katabuchi H, Nagase S, Mandai M, Yaegashi N, Yamagami W, Mikami M
- KMID: 2536009
- J Gynecol Oncol.
- 2022 Jan;33(1):e3.
- doi: 10.3802/jgo.2022.33.e3
Objective Associations between hospital treatment volume and survival outcomes for women with 3 types of gynecologic malignancies, and the trends and contributing factors for high-volume centers were examined. Methods The Japan Society of... -
- CITED
-
- Close
- SHARE
-
- Close
- The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG
-
Kondo E, Tabata T, Suzuki N, Aoki D, Yahata H, Kotera Y, Tokuyama O, Fujiwara K, Kimura E, Terauchi F, Sumi T, Okamoto A, Yaegashi N, Enomoto T, Sugiyama T
- KMID: 2512059
- J Gynecol Oncol.
- 2020 Nov;31(6):e94.
- doi: 10.3802/jgo.2020.31.e94
Objective: In this study we sought to investigate the clinical factors that affect postprogression survival (PPS) in patients with recurrent or persistent clear cell carcinoma (CCC). We utilized the JGOG3017/Gynecological Cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee
-
Shigeta S, Nagase S, Mikami M, Ikeda M, Shida M, Sakaguchi , Ushioda N, Takahashi , Yamagami W, Yaegashi N, Udagawa Y, Katabuchi
- KMID: 2413202
- J Gynecol Oncol.
- 2017 Nov;28(6):e76.
- doi: 10.3802/jgo.2017.28.e76
OBJECTIVE: The Japan Society of Gynecologic Oncology (JSGO) published the first practice guideline for endometrial cancer in 2006. The JSGO guideline evaluation committee assessed the effect of this guideline introduction... -
- CITED
-
- Close
- SHARE
-
- Close
